Celecoxib in Preventing Skin Cancer

NCT00025051 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)